SEC Form 4 · accession 0001140361-15-006731
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Hawkins
Director
Period of report
Feb 13, 2015
Accepted (ET)
Feb 13, 2015 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 41,926 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy)F1 | $0.47 | Feb 13, 2015 | A | 25,000 | A | Mar 13, 2015 | Feb 13, 2025 | Common Stock | 25,000 | 167,130 | D |
Explanation of responses
- F1The stock options vest 1/12th each month from date of grant, subject to the terms of the Company's 2014 Equity Incentive Plan.